The National Institutes of Health (NIH) is the largest science and medical research institute in the world. NIH’s more than 100 technology transfer professionals help hundreds of researchers – from basic to translational to clinical – patent their discoveries and license them to companies so they progress towards the marketplace. Long thought of as the go-to place for academics, NIH’s technology transfer offices are open for business – as one of the go-to places for the healthcare industry to work with a thought-leader, overcome a technology or knowledge gap, and get their products to market.

Translational and clinical innovators across 27 Institutes and Centers cover nearly every disease and disorder imaginable – and marketable. We develop drugs – as well as devices, diagnostics, wearable and digital health solutions, and software. We have the largest clinical center in the world – where >1000 trials run concurrently – provide clinical validation studies of first-in-human medical solutions. Our industry-friendly business terms include no up-front equity for licensees and a highly competitive overhead rate for collaborative projects. This webinar will introduce buy-side stakeholders (such as companies, entrepreneurs, investors, trade associations, economic development entities, family offices, foundations) to NIH’s technology development and commercialization activities that could benefit your pipeline and bottom line.

SESSION

• Brief overview + technologies interesting for more mature companies. (30 minute presentation + 15 minute Q&A)
• Agenda includes:
  • Introduction to the NIH as a technology development and commercialization partner
  • Value-add to larger companies of working with the NIH
  • Case studies of products co-developed with the NIH
  • Public market success stories; i.e., examples of blockbuster products brought to market by partnering with, or licensing from, the NIH

To be added to the webinar, email CBSA Event Coordinator, Natalie at nallen@cobioscience.com